These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 21393565
1. MET expression and amplification in patients with localized gastric cancer. Janjigian YY, Tang LH, Coit DG, Kelsen DP, Francone TD, Weiser MR, Jhanwar SC, Shah MA. Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1021-7. PubMed ID: 21393565 [Abstract] [Full Text] [Related]
2. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H, Ochiai A. Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858 [Abstract] [Full Text] [Related]
3. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status. Onitsuka T, Uramoto H, Ono K, Takenoyama M, Hanagiri T, Oyama T, Izumi H, Kohno K, Yasumoto K. J Thorac Oncol; 2010 May; 5(5):591-6. PubMed ID: 20150826 [Abstract] [Full Text] [Related]
9. Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer. Pelosi G, Gasparini P, Conte D, Fabbri A, Perrone F, Tamborini E, Pupa SM, Ciravolo V, Caserini R, Rossi G, Cavazza A, Papotti M, Nakatani Y, Maisonneuve P, Pastorino U, Sozzi G. J Thorac Oncol; 2016 May; 11(5):718-728. PubMed ID: 26804638 [Abstract] [Full Text] [Related]
10. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, Kang WK, Park JO. Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128 [Abstract] [Full Text] [Related]
11. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma. Zhang J, Guo L, Liu X, Li W, Ying J. Oncotarget; 2017 Feb 07; 8(6):10264-10273. PubMed ID: 28052014 [Abstract] [Full Text] [Related]
13. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy. An X, Wang F, Shao Q, Wang FH, Wang ZQ, Wang ZQ, Chen C, Li C, Luo HY, Zhang DS, Xu RH, Li YH. Cancer; 2014 Mar 01; 120(5):675-82. PubMed ID: 24804300 [Abstract] [Full Text] [Related]
14. Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer. Peng Z, Li Z, Gao J, Lu M, Gong J, Tang ET, Oliner KS, Hei YJ, Zhou H, Shen L. Mol Cancer Ther; 2015 Nov 01; 14(11):2634-41. PubMed ID: 26330547 [Abstract] [Full Text] [Related]
15. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Ha SY, Lee J, Kang SY, Do IG, Ahn S, Park JO, Kang WK, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Ignatius Ou SH, Kim KM. Mod Pathol; 2013 Dec 01; 26(12):1632-41. PubMed ID: 23807774 [Abstract] [Full Text] [Related]
16. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases. Tran TN, Selinger CI, Kohonen-Corish MR, McCaughan B, Kennedy C, O'Toole SA, Cooper WA. Clin Lung Cancer; 2016 Jan 01; 17(1):30-8.e1. PubMed ID: 26395411 [Abstract] [Full Text] [Related]
17. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. Kim HS, Chon HJ, Kim H, Shin SJ, Wacheck V, Gruver AM, Kim JS, Rha SY, Chung HC. J Surg Oncol; 2018 Jun 01; 117(8):1679-1686. PubMed ID: 29790169 [Abstract] [Full Text] [Related]